Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
2003 · PubMed · 125 citations
H
Hui‐Kuo G. Shu
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
416
Papers
9.7K
Citations
48
h-index
141
i10-index
Hui‐Kuo G. Shu is an academic researcher from Emory University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Meningioma and schwannoma management. The author has an h-index of 48, co-authored 354 publications.
ORCID: 0000-0002-4060-0874Papers by this author
worksMelatonin alleviates lipopolysaccharide-compromised integrity of blood-brain barrier through activating AMP-activated protein kinase in old mice
2017 · Aging Cell · 75 citations
https://doi.org/10.1111/acel.12572
Brain tumor segmentation using 3D Mask R-CNN for dynamic susceptibility contrast enhanced perfusion imaging
2020 · Physics in Medicine and Biology · 53 citations
https://doi.org/10.1088/1361-6560/aba6d4
Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
1990 · Proceedings of the National Academy of Sciences · 50 citations
https://doi.org/10.1073/pnas.87.23.9103
MRI-Based Proton Treatment Planning for Base of Skull Tumors
2019 · International Journal of Particle Therapy · 46 citations
https://doi.org/10.14338/ijpt-19-00062.1
Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death Switch
2013 · Cell Reports · 42 citations
https://doi.org/10.1016/j.celrep.2013.07.025
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat